4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-011991
President, R&D sold 22,994 shares at an average $20.94 ($481,577)
- President, R&D acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-02-22 | Option exercise | +8,000 | $4.12 | $32,960 | 117,920 | D: show line 1 in the form |
| Bergstrom Donald A President, R&D | 2022-02-22 | Sale | −8,000 | $20.94 | $167,520 | 109,920 | D: show line 2 in the form |
| Bergstrom Donald A President, R&D | 2022-02-22 | Sale | −12,242 | $20.94 | $256,347 | 97,678 | D: show line 3 in the form |
| Bergstrom Donald A President, R&D | 2022-02-22 | Sale | −2,752 | $20.97 | $57,709 | 94,926 | D: show line 4 in the form |
| Open-market sales · 22,994 sh · avg $20.94 · $481,577 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-02-22 | Option exercise · Stock Option (Right to Buy) | −8,000 | 245,456 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…